N
Minerva Neurosciences, Inc.
NERV · NASDAQ · Healthcare · 213M
Closing price
$3.18
-1.24% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-0.0×
Free cash flow yieldFCF yield
-50197.6%
Return on equityROE
208.5%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.